Corindus Vascular Robotics (CVRS) Reports In-Line Q4 EPS

Corindus Vascular Robotics (NYSE: CVRS) reported Q4 EPS of ($0.04), in-line with the analyst estimate of ($0.04). Revenue for the quarter came in at $4.7 million versus the consensus estimate of $4.77 million.

For earnings history and earnings-related data on Corindus Vascular Robotics (CVRS) click here.

You May Also Be Interested In

• H2O America (HTO) Tops Q2 EPS by 2c ; Offers Guidance
• Christopher & Banks (CBK) Reports Q2 EPS of $0.75
• Philips (PHG) Tops Q2 EPS by 9c; offers outlook